Skip to main content

Advertisement

Table 1 Clinical and histopathological data

From: Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

  MS IHC: Small cohort group IHC: Large cohort group IHC: Clinically difficult cases
PHC DCC PHC DCC PHC DCC PHC DCC
N 10 8 12 12 72 74 5 2
Sex
 Male 5 5 8 10 38 55 5 1
 Female 5 3 4 2 34 19 0 1
Age
 Mean 64.5 70.1 65.4 73.4 63.1 68.6 70.2 63
 Range 48–79 60–76 50–82 63–79 27–82 47–83 65–76 52–74
Histology
 Well 0 4 1 2 8 12 1 0
 Moderate 10 4 9 6 61 55 4 1
 Poor 0 0 1 2 3 7 0 1
UICC Stage
 I 1 4 0 2 7 24 0 0
 II 8 4 9 9 52 48 5 1
 III 1 0 0 0 1 0 0 0
 IV 0 0 3 1 12 2 0 1
  1. MS Mass spectrometry, IHC Immunohistochemistry, PHC Pancreatic head cancer, DCC Distal cholangiocarcinoma, UICC Union for international cancer control